CJC-1295 and ipamorelin: check each ingredient
A study of CJC-1295 alone does not establish the benefits or safety of a CJC-1295/ipamorelin blend.
RateMyLab editorial·
What did the CJC-1295 study measure?
Two short trials in healthy adults measured growth hormone and IGF-I responses to CJC-1295. They studied CJC-1295, not a blend with ipamorelin. Read the 2006 trial report. Hormone changes alone do not establish better recovery, longer life, or a benefit from a different product.
What is in the blend?
Ask for the exact form of CJC-1295 and the amount of each ingredient. A combined vial weight does not tell you how much CJC-1295 or ipamorelin it contains. For research purchases, request specifications and batch results for both.
What safety concerns should I know about?
The FDA describes limited clinical data for CJC-1295, including reports of increased heart rate, and gaps in safety information for some injectable routes of ipamorelin. Read the separate FDA entries.
What should I ask about a treatment claim?
Ask whether the cited study used the same ingredients, formulation, and route, and whether it measured the outcome you care about. Do not use an online research listing as a self-treatment protocol.
Sources checked September 13, 2026. This guide is educational and does not provide a dosing or treatment plan.